BackgroundChlorinated poly uorinated ether sulfonic acids (Cl-PFESA 6:2 and 8:2), used as per uorooctane sulfonate (PFOS) alternatives, affect lipid metabolism in vivo and in vitro studies. The association between Cl-PFESAs exposure and the prevalence of overweight /obesity in human is unknown.
ObjectivesWe investigated associations of serum 6:2 Cl-PFESA and 8:2 Cl-PFESA with overweight/obesity status in adults.
MethodsWe quanti ed four per uoroalkyl substances (PFAS), including 6:2 Cl-PFESA, 8:2 Cl-PFESA, PFOS, and per uorooctanoic acid (PFOA) in 1275 Chinese adults from the Isomers of C8 Health Project in China study. Participants were categorized into normal weight group [body mass index (BMI) < 25 kg/m 2 ] and overweight/obesity group (BMI ≥ 25 kg/m 2 ).
ResultsAdjusted for potential confounders, BMI in the second quartile of each ln-ng/mL greater concentration of 6:2 Cl-PFESA and 8:2 Cl-PFESA were 0.45 [95% con dence interval (CI): 0.08, 0.82], and 0.39 (95% CI:0.03, 0.76) signi cantly higher than the lowest quartile, respectively. Cl-PFESAs displayed inverted U-shaped associations with the risk of overweight/obesity, and the in ection point of 6:2 Cl-PFESA and 8:2 Cl-PFESA were 1.80 ng/mL, 0.01 ng/mL, respectively. PFOS was associated with waist circumference (WC) but not BMI in each quartile. For PFOA, the associations with outcomes were linearly positive (P for trend < 0.05).
ConclusionsThis study reports the rst observations on non-monotonic associations between serum 6:2 Cl-PFESA and 8:2 Cl-PFESA concentrations and the prevalence of overweight/obesity in adults. More epidemiological investigations are required to con rm the observed associations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.